Evidence map›Paper›PMID 24038728›Full record

Trial reportDepression and anxiety2013

Sleep quality predicts treatment outcome in CBT for social anxiety disorder.

Alyson K Zalta, Sheila Dowd, David Rosenfield, Jasper A J Smits, Michael W Otto, Naomi M Simon, Alicia E Meuret, Luana Marques, Stefan G Hofmann, Mark H Pollack

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Depression and anxiety, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02325128 (Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps), which is not on this map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02325128 nacompletednot on this mapstarted 2015, after this paper: background citation

Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps

TypeinterventionalSponsorMassachusetts General HospitalRan2015 to 2016Enrolled35ConditionsSocial Anxiety Disorder, Sleep LaboratoryArmsSleep-enhancement of extinction memory
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review.The international journal of neuropsychopharmacology · 2016
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Sleep dysfunction in social anxiety disorder.The British journal of clinical psychology · 2026
    Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Neurocognitive Model of Schema-Congruent and -Incongruent Learning in Clinical Disorders: Application to Social Anxiety and Beyond.Perspectives on psychological science : a journal of the Association for Psychological Science · 2023
    Article
  15. Review
  16. Article
  17. The Impact of Sleep on Fear Extinction.Current topics in behavioral neurosciences · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alyson K ZaltaDepartment of Psychiatry, Rush University Medical Center, Chicago, IL; Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL.
Sheila Dowd
David Rosenfield
Jasper A J Smits
Michael W Otto
Naomi M Simon
Alicia E Meuret
Luana Marques
Stefan G Hofmann
Mark H Pollack

Funding

D-Cycloserine Enhancement of Exposure in Social PhobiaR01MH075889 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI POLLACK, MARK H · 2007 to 2010
$1.8M
D-Cycloserine Enhancement of Exposure in Social PhobiaR01MH078308 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HOFMANN, STEFAN G. · 2007 to 2010
$1.3M
IMPLEMENTATION OF COGNITIVE PROCESSING THERAPY FOR PTSD IN DIVERSE COMMUNITIESK23MH096029 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI MARQUES, LUANA · 2012 to 2016
$931k
NIMH NIH HHS K23 MH096029NIMH NIH HHS R01 MH075889NIMH NIH HHS R01MH075889NIMH NIH HHS R01 MH078308NIMH NIH HHS R01MH078308
6 · The paper itself

Abstract

backgroundSleep quality may be an important, yet relatively neglected, predictor of treatment outcome in cognitive-behavioral therapy (CBT) for anxiety disorders. Specifically, poor sleep quality may impair memory consolidation of in-session extinction learning. We therefore examined sleep quality as a predictor of treatment outcome in CBT for social anxiety disorder and the impact of d-cycloserine (DCS) on this relationship.

methodsOne hundred sixty-nine participants with a primary diagnosis of DSM-IV generalized social anxiety disorder were recruited across three sites. Participants were enrolled in 12 weeks of group CBT. Participants randomly received 50 mg of DCS (n = 87) or pill placebo (n = 82) 1 hr prior to sessions 3-7. Participants completed a baseline measure of self-reported sleep quality and daily diaries recording subjective feelings of being rested upon wakening. Outcome measures including social anxiety symptoms and global severity scores were assessed at each session.

resultsPoorer baseline sleep quality was associated with slower improvement and higher posttreatment social anxiety symptom and severity scores. Moreover, patients who felt more "rested" after sleeping the night following a treatment session had lower levels of symptoms and global severity at the next session, controlling for their symptoms and severity scores the previous session. Neither of these effects were moderated by DCS condition.

conclusionsOur findings suggest that poor sleep quality diminishes the effects of CBT for social anxiety disorder and this relation is not attenuated by DCS administration. Therapeutic attention to sleep quality prior to initiation of CBT and during the acute treatment phase may be clinically indicated.

Indexed as

Treatment OutcomeAdultAntimetabolitesBehavior TherapyCognitive Behavioral TherapyCombined Modality TherapyComorbidityCycloserineHumansImplosive TherapyPhobic DisordersPlacebosPredictive Value of TestsPsychiatric Status Rating ScalesSeverity of Illness IndexSleep Wake DisordersAntimetabolitesCycloserinePlaceboscognitive behavioral therapyd-cycloserinepsychotherapysleep qualitysocial anxiety disordersocial phobia

Identifiers

PMID24038728
PMCPMC4043139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.